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Abstract 
Cancer screening programs have the potential to decrease psychosocial wellbeing. This review 
investigates the evidence that anal cancer screening has an impact on psychosocial functioning and 
outlines considerations for supporting participants. The review suggested that screening has no 
significant effect on general mental health but may increase cancer-specific worry. Having worse anal or 
HIV symptoms, being younger, higher baseline distress or worse histology results were predictive of 
greater worry. The findings suggest the need to increase education campaigns, particularly targeting 
those with HIV infection and men who have sex with men. There is a need to develop a consensus on 
measuring the psychosocial impact of screening and stepped care approaches for responding to any 
resulting distress. 
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Abstract:  
Cancer screening programs have the potential to decrease psychosocial well-being. This 
review investigates the evidence for anal cancer screening having an impact on psychosocial 
functioning and outlines considerations for supporting participants. The review suggested that 
screening has no significant effect on general mental health but may increase cancer-specific 
worry. Having worse anal or HIV symptoms, being younger, higher baseline distress or 
worse histology results were predictive of greater worry.  The findings suggest the need to 
increase education campaigns particularly targeting those with HIV infection and men who 
have sex with men. There is a need to develop a consensus on measuring psychosocial impact 
of screening and stepped care approaches for responding to resulting distress.  
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Introduction 
Early detection screening programs are recommended for a variety of cancer types.  
While there are well established population screening programs for other cancers, anal cancer 
has not been recognised as a high priority for screening until the last 5 to10 years 1-3. High 
rates of HPV infection and anal cancer in HIV-infected individuals and men who have sex 
with men (MSM) have led to a growing concern that screening, prevention and early 
intervention efforts need to be implemented, similar to other cancers 4. Baseline and annual 
follow up anal cytological screening is recommended for HIV-infected individuals in the 
New York State Guidelines. The need for screening programs has been recognized with 
research studies being conducted in North America5, 6, Europe7 and Australia8.  
Progression and regression rates from HPV infection to anal cancer are unknown, but 
the screening process is similar to the highly effective cervical cancer model 4. While there is 
no universally accepted anal cancer screening or treatment protocol, typically, the screening 
process involves two stages. A swab is taken and sent for cytological analysis and if further 
investigation is warranted from non negative cytology results, a high resolution anoscopy 
(HRA; similar to colposcopy) is conducted to determine the extent of disease via biopsy and 
histology results. The HRA process is potentially uncomfortable and painful. Additionally it 
is during the waiting periods for both sets of results and for the HRA procedure that patients 
may experience increased distress about the potential for bad news. The severity of result 
may have an effect on the psychosocial response. Specifically, different results are likely to 
convey different levels of perceived risk of disease. For example, the distinction between 
cancer and pre-cancer cytological and histological results can be difficult for patients to 
understand. In a related area, cervical screening participants found it, “difficult to understand 
cell changes as anything other than a life-threatening illness” 9. Levels of education, personal 
experience with cancer (self or others) and psychological status are all possible moderators of 
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the psychosocial response to screening. Both researchers and clinicians’ highlight the need to 
understand the potential psychosocial impact of screening programs, particularly in response 
to uncertainty associated with screening, procedures and results 10-14.  
Potential psychosocial impacts in anal cancer screening 
The psychosocial impact of anal cancer screening has not been widely investigated in 
comparison to other forms of cancer. There are numerous studies and systematic reviews 
examining the psychological effects of cervical15, prostate16 and breast17 cancer screening 
programs and these provide valuable insights into the potential psychosocial effects of anal 
cancer screening.  
The anal cancer screening process is similar to both prostate and cervical cancer 
screening on several dimensions. For example, they are associated with private parts of the 
body and related to sexuality. The screening process has two stages and is very similar to 
cervical and slightly different to prostate, with a blood test for prostate specific antigen (PSA) 
followed by transrectal ultrasound-guided and random biopsy.  
Increased anxiety, worry about cancer and lower sexual well-being has been found 
with all grades of cervical cytology results18-20. Rates of return for repeat testing are lower in 
those who are most anxious 19. Men with normal PSA results were less worried than men 
with benign biopsies even after 12 months. Those with benign biopsies had sought more 
medical follow up, talked more to their partners and sought information from the internet 11, 
21. It may be that repeat testing, biopsy and concern about false negative biopsies contributed 
to the ongoing anxiety found, particularly as random biopsy is likely to miss 10% of men 
with active disease 21. While HRA is more targeted than the prostate biopsy process there 
may be false negative rates in that process as well.  
Other factors that have impacted psychosocial responses are having symptoms prior 
to testing; for example men with urinary symptoms 23or higher anxiety at baseline 21, 24. 
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Having more or less knowledge about the screening and disease are also potential factors.   
Men who had multiple PSA testing points had increased anxiety at the second and subsequent 
tests. This may be due to awareness of cancer being raised by the initial PSA result and 
increasing with each re-test 25. In contrast, having repeated biopsies did not increase anxiety 
25 and although speculative, it is possible that repeated biopsy was viewed as a more thorough 
test and increased reassurance. Being given cervical HPV results increased anxiety15, in part 
due to poor understanding and confusion about HPV infection, particularly the difference 
between genital warts and high-risk HPV. When women sought information, their anxiety 
diminished over time 15. Knowing that HPV can clear on its own and that it would not cause 
genital warts also reduced anxiety 26. 
Test specific psychological questionnaires (TSPQ) whether it be cervical or prostate 
compared to generalised psychological questionnaires (GPQ) appear to be associated with 
greater sensitivity to psychosocial responses to screening 11, 22 and may explain conflicting 
results between different studies.  A number of studies have found that PSA and biopsy 
results did not increase anxiety, depression or health related quality of life (QOL) using 
GPQ23-25. It may be important for future studies to utilize TSPQ.  There are psychosocial 
impacts from cervical and prostate screening processes and the full range of results; better 
information can improve psychosocial responses.  
Aims 
Screening programs have the potential to decrease psychosocial well-being and increase 
avoidance of health testing.  There have not been many direct studies in the anal cancer field, 
so this systematic review will also integrate findings from other relevant cancer screening 
areas. The aim is to identify the likely psychosocial effects of anal cancer screening and then 




A search of four electronic databases using standard research procedures was conducted in 
October 2011. The databases were Medline, PsychInfo, Cumulative Index of Nursing and 
Allied Health Literature (CINAHL) and Web of Science. Search terms were entered with 
combined sets of terms relating to anal cancer, screening and psychosocial impact; (anal) and 
(cytol* or screen*) and (psyc* or anxi* or worry). These four searches identified 200 articles, 
7 were unique and directly relevant to the review. It was not possible to combine the data 
from these studies in order to conduct a meta-analysis due to the highly variable measures 
and methods used. 
Inclusion and exclusion criteria 
Exclusion criteria were minimal, given the scarcity of publications on this topic. All 
theoretical, descriptive or empirical studies on psychosocial characteristics of anal cancer 
screening were included. Titles and abstracts were reviewed for the following inclusion 
criteria:  
 Presented original research on psychosocial aspects of cancer screening 
 Screening was for anal cancer 
 Published in English 
Articles were further excluded if they described cost effectiveness, surveyed health care 
workers only, focused solely on patients diagnosed with cancer or the effects of cancer 
treatment.  
In order to assess one aspect of study quality and to begin describing the diverse 
psychosocial domains investigated, those studies that used psychological measures with some 
previously assessed reliability and validity were identified. Measures assessed in other cancer 
screening contexts (e.g., cervical) were considered to have some established reliability and 
validity. Table 1 summarises the seven studies. 
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Results 
Measures of psychosocial functioning 
The articles reviewed used a combination of validated and nonvalidated self-report 
psychological measures which are listed in Table 1. The validated measures are indicated in 
Table 1, they can be categorized into GPQ’s; for example, Hospital Anxiety and Depression 
Scale and TSPQ’s such as, Psychological Consequences Questionnaire positive scale, 
developed for impact of mammography screening on physical, social and emotional domains. 
The non-validated measures were unique to each study and were related to knowledge of 
HPV, anal cancer and anal pap tests; attitudes or beliefs; willingness to seek or return to 
screening and evaluating screening procedures. All measures which were readily available 
are in Appendix 1. 
Knowledge, attitudes & willingness to have screening  
Knowledge 
The majority of studies had a knowledge assessment component. The first published study on 
knowledge was in 2007 by Pitts et al. 27, who found no single item was answered correctly by 
more than half of the sample and awareness of risk factors was poor. For example 
respondents had low awareness of risk factors such as HPV, smoking and being a receptive 
sexual partner. While 62% had received a sexual health screen in the past 12 months this was 
not associated with better knowledge. Significantly higher knowledge was found in those 
who had higher education 27, had ever had an anal pap screen 28, 29 and among those 
undergoing regular screening (RF) compared to patients lost to follow up (LTF)30. Amongst 
participants who had higher levels of knowledge or awareness of screening availability, there 
was greater willingness to have screening 28, 29.  
Willingness 
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Three studies28-30 investigated factors related to intentions or willingness to participate in 
screening. Being HIV-infected was related to being more willing to be screened 28, 29. Men 
indicated they were more willing to have screening that would be free (83%) than if they 
incurred out of pocket costs of $150 (31%) 29. Those with household incomes over $60,000 
were also more willing to be screened than those earning less 29. Truesdale and Goldstone 30 
investigated factors related to men who have sex with men (MSM) with both low and high 
grade squamous intraepithelial lesions (LSIL & HSIL) returning to screening after 1 year. It 
was found that having more sexual partners led to greater rates of return, with each additional 
partner increasing likelihood of return by 8%. Return to screening was related to being 
contacted to take part in the study, leading to 7% of LTF having further screening and 18% of 
the LTF participants returning for screening. Twelve percent of MSM indicated that the anal 
pap smear was “too painful to make it worthwhile” 30. 
Worry 
A variety of concerns or worries were related to knowledge and willingness to have 
screening. Participants who described learning they had HPV as “upsetting” were 3 times 
more likely to have regular follow up (RF) than be lost to follow up (LTF) 30. Furthermore, 
when treatment was prescribed at diagnosis participants were 2 times more likely to be RF 
than LTF 30. Having greater worry about or higher perceived likelihood of getting anal cancer 
was related to being more willing to have screening. Physical symptoms were strong 
motivators for the RF group and those who reported physical symptoms were 10 times more 
likely to return to screening after being lost to follow up 30. The severity of diagnosis was 
related to more compliance with screening. Those in the RF group were more likely to have 
HSIL and those with HSIL were 4 times more likely to be to be in the RF group than those 
with LSIL 30. Being concerned about anal cancer was higher in HIV-infected men 28 and 
those having a history of anal warts in the last 6 months or ever 28. Willingness to have 
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screening was lower when men were concerned about accuracy of the test, embarrassed about 
asking for or having the pap test 29.  
Sexuality 
Two of the studies investigated some aspect of sexual function or beliefs. The patients who 
participated in regular follow up (RF) were two times more likely to agree that ‘finding out I 
had HPV made me feel promiscuous’ 30. Those who were recalled for further investigation 
rated their anal health lower than those who did not need further investigation 31.   
Evaluation of screening procedure 
One study directly investigated the acceptability of the self collected Dacron swab screening 
procedure 8. The anonymous evaluation found that 53% rated the swab easy to collect, 81% 
rated the process highly acceptable, 65% reported no pain and 83% reported no bleeding 8. 
As these questionnaires were anonymous they were not able to investigate any factors 
associated with better or worse responses and they did not ask about participant’s willingness 
to repeat the test. Self-collected screening was generally acceptable and therefore has the 
potential to allow for home testing, which has the potential to reduce the costs of screening 
programs.  
Psychosocial impact of screening 
Two studies have investigated the psychosocial impact of the screening process 
longitudinally. Tinmouth et al 6 (study 1) used 4 time points over 6 months and Landstra et al 
31 (study 2) used 3 time points over 3 months. These studies had different time lines for 
medical procedures with study 1 occurring in a research context. Study 1 6 had the swab and 
HRA conducted at the same time, thereby giving all participants both procedures and having 
only one time frame to wait for results. In contrast, study 2 31 demonstrated a more common, 
two stage screening process, where swab results determined who was recalled for HRA, 
thereby requiring some participants to return and wait for results twice. Both studies found no 
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general impact on psychological health in terms of depression or anxiety 6, 31, nor effects on 
stress or QOL 31 using GPQ’s.  
There was some discrepancy between these studies regarding who is impacted and 
when. Study 1 found those with anal intraepithelial neoplasia (AIN) 2/3; high grade 
precancerous lesions were no more impacted than others with lesser results6. In contrast  
study 2 found that being referred for HRA led to higher worry and subsequently those with 
high grade anal intraepithelial neoplasia (HGAIN; equal to AIN 2/3) continued to be worried 
31. The time of most negative impact in study 1 was waiting for results to be given 6. In study 
2 waiting for further investigation by HRA was the time of most impact 31. These differences 
may be due to study 1 using GPQ’s and study 2 using TSPQ’s. Alternatively, it may have 
been due to study 1 having both the swab and HRA completed in one visit while study 2 
followed a two step screening process. 
Other results of importance in the studies are that participants who received negative 
results from the HRA were more optimistic about their future health than those who did not 
need an HRA31. Thus, negative results may lead to “unrealistic optimism”. Characteristics 
that were predictive of greater worry were being younger, having more HIV symptoms and 
greater baseline psychological distress 6.  Both studies demonstrated that there is some 
psychosocial impact from anal cancer screening, namely increased worry and concern and 
this is similar to prostate and cervical screening.  
Limitations of the studies 
These studies have a number of limitations in common. All studies were completed with gay 
men only and did not include other at risk populations, such as women with HIV or prior 
HPV related cervical disease and immunosuppressed transplant recipients.  Most participants 
were Caucasian, well educated, and in some studies most had private health insurance. These 
characteristics may not reflect the general MSM or HIV-infected population. The vast 
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majority of studies used different questionnaires and therefore could not be compared. 
Participants were voluntary or convenience samples which may have skewed the results 
towards participants who were more interested, knowledgeable or more connected to the gay 
community 27. Hypothetical statements were used by Reed 29 and these could have failed to 
anticipate barriers to screening. The availability of screening was not independently 
determined in D’Souza’s study 28 and therefore the lower perceived screening availability 
may not reflect the actual availability of screening programs. The two longitudinal screening 
studies 6, 31 used different medical process timelines and swab collection procedures (self 
collected vs. clinician collected), making comparison between them difficult.  
Discussion 
Summary of Results 
Anal cancer screening appears to generate health worries specific to the procedure. Thus far, 
research suggests no acute or clinically significant levels of mental health problems as a 
result of screening. Most screening participants experienced no significant psychosocial 
impact, but there was some individual variation, suggesting some with particular 
characteristics were affected more than others. Having worse anal or HIV symptoms, being 
younger, higher baseline distress or worse histology results were predictive of greater worry. 
Worry in this context involved repetitive thoughts about the screening and the possibility of 
having anal cancer. Furthermore, there was generally poor knowledge of anal cancer, anal 
pap testing and HPV or other risk factors and low willingness or intention to screen.  
Clinical implications: what to consider when setting up routine anal cancer screening 
Education 
Given the low levels of knowledge in the MSM’s studied and its links to screening 
adherence, it is important to have targeted education campaigns about the risk of anal cancer 
and the need for screening. This education is particularly important for high risk groups such 
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as HIV-infected MSM. Raising knowledge may increase concern and perceived vulnerability 
and therefore increase motivation to have screening. Striking the balance between raising 
awareness and inducing fear is important as some levels of worry may cause avoidance. For 
example, women at high risk of breast cancer with mild distress were more likely to have 
screening than those with moderate distress32. Hay et al. 32 conclude that cancer worry 
increases the likelihood of screening but fear of positive results or the test itself may deter 
screening.  
Primary care physicians were the most common point for sexual health screening and 
potential contacts for anal cancer screening. Thus, primary care physicians are critical to 
educational efforts and to encouraging screening. It has been suggested that, “primary care 
physicians should be prepared to counsel their patients about the pros and cons of anal cancer 
screening and be familiar with anal health services in their local communities”28.  
Information about the costs of screening and follow up care need to be part of 
educational campaigns. In areas where there are few public or affordable opportunities, 
policy advocacy could be very important. While there are a number of research studies on 
anal cancer screening, there is still debate about cost effectiveness and guidelines for regular 
screening. Despite such debate, most countries have a need to increase the availability of 
screening and skilled clinicians in the follow-up of abnormal anal cytology results. 
Managing the screening process 
The screening process itself needs to have clear and appropriately pitched education 
materials. Having communication regarding the procedure itself, expected adverse events, 
recovery and non technical explanations of results are essential to support the participants 12, 
33, 34. The potential benefits of information are reflected in findings from cervical screening. 
Providing written information about the meaning of an abnormal pap smear resulted in less 
anxiety and fewer patients thinking they had cancer 35. Written and verbal explanations of 
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abnormal pap smear results led to better understanding of results and better attendance for 
follow up colposcopy than written information alone 36.  
The choice of materials to gather the swab is also important. Such choices require a 
balance between the need for good quality specimens and methods that reduce discomfort as 
part of the collection process. Inadequate specimens have the potential to increase anxiety if 
results are inconclusive19. In the evaluation of self collected Dacron swabs, 35% reported 
some level of pain and 17% reported some level of bleeding 8. In another study, 12% reported 
that the screening was too painful to be worthwhile 30. Some clinics use a cytobrush which 
gathers more satisfactory specimens and may also be more painful and lead to more bleeding. 
The vigor which is used in collecting the specimen may also have an impact. Making sure 
participants are sufficiently prepared for the method used, potential adverse events and level 
of pain is important, to increase the probability for that person to return for screening. It is 
also important given they may also talk within their social networks and provide word of 
mouth recommendations or warnings. Providing the option of self-collection rather than 
clinician collection may give the participant control over the level of pain. Where there is 
poor availability of screening, doing home screening with self-collection may be an 
alternative method to reach those at risk.  
Support after screening and results  
Waiting for results and further investigation were the times of greatest psychosocial distress. 
It is these times that participants could benefit from support. Different types of support may 
be needed by different people. Where possible it would be helpful to have a variety of 
support options available such as written information, support staff available by phone or 
email, patient support groups or access to a psychologist or social worker. We have 
developed a stepped care model outlined in Table 2 to offer suggestions for how to triage 
those who may need extra support beyond information37. Recognition of risk factors for 
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psychosocial distress is an important part of this process (e.g., younger age, physical anal 
symptoms, more HIV symptoms, higher baseline distress, worse screening results). Using 
TSPQ was more sensitive than GPQ. For example, the distress thermometer, cancer worry 
scale, or impact of events scale may be quick and easy ways to check level of distress or 
concern at the time of screening. Those with higher levels of baseline distress should be 
linked to available supports or encouraged to call for support. Other indictors that participants 
are at risk of a more negative response to screening might include a lack of information 
seeking (raising concerns of avoidance) or the expression of excessively negative emotions 
about their results 38.  
Similar to the lack of universally accepted protocols for screening, treatment protocols 
are also not well established as there is an absence of data from randomized treatment trials 
of HGAIN showing reduction of anal cancer. One post screening option is active surveillance 
with no active treatment but ongoing monitoring and assessment. It is estimated that half the 
men diagnosed with early prostate cancer have unnecessary treatment that has many physical 
side effects and negative effects on QOL 22. Similar concerns may be present for 
precancerous anal lesions which have significant natural regression rates suggesting they may 
not worsen with time. Some clinicians may take an active surveillance approach rather than 
treatment. If this is the case there are some strategies which can be implemented to support 
the patient. In a review of active surveillance for early prostate cancer Pickles et al. 22 found 
that this option creates anxiety, but audio-taping treatment consultations for the patient 
improved understanding and decision making. The doctor’s role in creating clear “rules” 
about when to initiate treatment and ways to gain quality information were also important. 
Another strategy is to actively manage the anxiety that may be created by uncertainty and 
withholding active treatment. Options such as support groups or therapeutic groups focused 
on teaching mindfulness, stress management and other psychological therapies could be 
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offered. One promising therapeutic approach is Acceptance and Commitment Therapy, which 
helps participants to focus on accepting uncertainty and living a vibrant and valued life even 
with the ongoing threat of cancer. Use of acceptance based coping strategies, after receiving 
abnormal cervical pap smear results was associated with lower psychological distress 38.  
Supporting return for repeat screening 
Empirically supported screening guidelines have not been clearly established but, as with 
other cancer screening programs, regular screening may be important. Therefore being able to 
motivate participants to return is imperative. Finding the balance between reassurance and 
complacency is essential 25, 31. A concern in the screening process is the phenomenon of 
“unrealistic optimism” which has been found to hinder protective health behaviours. 
Intentions to participate in breast screening were lower when unrealistic optimism was higher 
39.  Three years after colorectal screening, the group who were reassured with negative results 
had significant increases in their body mass index compared to those with positive results 40. 
This may reflect unrealistic optimism and a resulting tendency to be less vigilant in following 
protective behaviours after being reassured. To protect against this phenomenon, clinicians 
could emphasize known risks such as HIV and HPV infection, numbers of sexual partners, 
unprotected receptive anal intercourse, and potential consequences of progression to anal 
cancer. Truesdale and Goldstone 30 highlight the need to stress the importance of repeat 
screening so the participant “hears” the message without becoming too alarmed. They found 
participants who were more emotionally upset at diagnosis returned for regular follow up. 
They also recommend a reminder system be “more extensive than a mailed reminder card or 
short telephone call”. Unnecessary mortality might be prevented by setting clear expectations 
for regular screening at the initial screening and result-giving stages and then following up 




Areas needing further research are impacts of screening on HIV-infected women, women 
with prior HPV related cervical disease and immunosuppressed transplant recipients, who are 
also at high risk. Research is also needed to examine the impact of screening on sexual 
functioning and related emotional responses, such as shame, embarrassment and self-stigma, 
as both cervical and prostate cancer have shown this to be an issue. For example, does self-
stigma prevent people from seeking screening, and if so, how can this barrier be addressed? 
There is a need to determine what types of support are most effective and we propose the 
stepped care model outlined in Table 2 as a starting point to develop this research, with a 
particular focus on motivating regular screening.  
Conclusions 
Anal screening does not appear to have a general impact on mental health, but in some 
instances does appear to increase health-related worry. A small proportion of people will 
need support and the most effective ways to do this have not yet been empirically tested. In 
order to identify those who will need support, it would be useful to have consensus on a core 
set of psychosocial screening measures and to establish cut off points that provide guidance 
about appropriate levels of response. Similar suggestions emerged from a review of prostate 
cancer screening 16. As anal cancer screening is not yet well established there is an 
opportunity to set up a consistent and evidence-based approach to measuring and responding 
to the psychosocial effects of screening.   
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